List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 5 studies with search of: "Oncotherapeutics" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting Doxorubicin Hydrochloride Liposome, Bortezomib, and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: bortezomib;   Drug: dexamethasone;   Drug: pegylated liposomal doxorubicin hydrochloride;   Genetic: protein analysis;   Other: immunologic technique
2 Active, not recruiting Bortezomib, Ascorbic Acid, and Melphalan in Treating Patients With Newly Diagnosed Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Dietary Supplement: ascorbic acid;   Drug: bortezomib;   Drug: melphalan
3 Active, not recruiting Samarium 153 and Bortezomib in Treating Patients With Relapsed or Refractory Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: bortezomib;   Radiation: samarium Sm 153 lexidronam pentasodium
4 Withdrawn Melphalan, Arsenic Trioxide, and Ascorbic Acid in Treating Patients With Relapsed or Refractory Multiple Myeloma
Conditions: Stage II Multiple Myeloma;   Stage III Multiple Myeloma;   Refractory Plasma Cell Neoplasm
Interventions: Drug: arsenic trioxide;   Drug: ascorbic acid;   Drug: melphalan;   Procedure: chemosensitization/potentiation;   Procedure: chemotherapy
5 Recruiting Melphalan and Panobinostat in Treating Patients With Recurrent Multiple Myeloma
Condition: Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Drug: melphalan;   Drug: panobinostat

Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options